We found that in CML cells the gene and protein expression of HERC1 seem to be sensitive to TKIs, whereas in the case of HERC2 such behavior was restricted only to the transcript. This evidence concerns the gene HERC1 and chronic myelogenous leukemia, BCR-ABL1 positive.